Machida, Japan

Sadamitsu Kono

This inventor holds 2 USPTO granted patents. Top assignee: Sogo Pharmaceutical Co., Ltd.. Active years: 1979-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sadamitsu Kono. Retrieved from https://idiyas.com/inventor/sadamitsu-kono

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1979-1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Sadamitsu Kono in Pharmaceutical Chemistry**

Introduction

Sadamitsu Kono, a prominent inventor based in Machida, Japan, has made significant strides in the field of pharmaceutical chemistry. With a keen focus on amidoxime derivatives, his innovative work has led to the development of valuable compounds that serve as intermediates in the synthesis of various medicines. Throughout his career, Kono has been granted two patents, underscoring his contributions to the industry.

Latest Patents

Sadamitsu Kono's most recent patents include groundbreaking formulations of novel amidoxime derivatives. These derivatives are characterized by their structural formulas, allowing for the efficient preparation of 3-amino-5-methyl isoxazole without generating any by-products of isomer. Specifically, his patents detail derivatives wherein R₁ represents a methyl or ethyl group, and R₂ represents hydrogen or methyl group, derived from β-amino crotonitrile. These innovations are particularly noteworthy for their utility as raw materials in pharmaceutical applications.

Career Highlights

Kono's journey in the pharmaceutical realm has been marked by dedication and ingenuity. Working with Sogo Pharmaceutical Co., Ltd., he has actively contributed to advancements in medicinal chemistry. His expertise in creating novel chemical compounds has positioned him as a valuable asset within the organization. With two patents to his name, Kono continues to push the boundaries of what's possible in drug development.

Collaborations

Throughout his career, Sadamitsu Kono has collaborated with esteemed colleagues, including Masataka Kuroki and Kazuyuki Shioka. Their joint efforts have further enhanced the innovative work being done at Sogo Pharmaceutical Co., Ltd., particularly in the exploration of amidoxime derivatives and their pharmaceutical applications. These collaborations have fostered an environment of creativity and scientific exploration that is essential for breakthroughs in the field.

Conclusion

Sadamitsu Kono exemplifies the spirit of innovation and perseverance in the world of pharmaceutical chemistry. With his significant contributions through two patents focusing on amidoxime derivatives, he continues to influence the development of essential medicines. As he collaborates with talented coworkers and further explores the potentials of his inventions, the future looks promising for both Kono and the broader pharmaceutical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…